Atazanavir and Cobicistat (EVOTAZ)
Questions a plan sponsor actually asks.
What is Atazanavir and Cobicistat used for?
Atazanavir and Cobicistat is tracked in Medicare Part D. Specific indication information is not available in our current dataset.
Is there a generic for Atazanavir and Cobicistat?
No. Atazanavir and Cobicistat is brand-only with no generic equivalents currently in market.
How much does my plan pay for Atazanavir and Cobicistat?
Across 329 Part D plans, Atazanavir and Cobicistat averages $52.05/unit (NADAC). Lowest available: $52.05/unit. Highest in distribution: $52.05/unit.
Is Atazanavir and Cobicistat on the FDA shortage list?
Atazanavir and Cobicistat has been discontinued by its manufacturer(s).
4 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (2 approvals on file) · NADAC unit costs: CMS NADAC weekly file (1 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.